Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0000919574-15-007187)

Filing Details

Accession Number:
0000919574-15-007187
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-02 20:02:25
Reporting Period:
2015-09-30
Filing Date:
2015-10-02
Accepted Time:
2015-10-02 20:02:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1327467 Celator Pharmaceuticals Inc CPXX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1576115 Valence Life Sciences Gp Ii Llc C/O Valence Life Sciences Llc
590 Madison Avenue, 21St Floor
New York NY 10022		 No No No Yes
1576244 W Eric Roberts C/O Valence Life Sciences Llc
590 Madison Avenue, 21St Floor
New York NY 10022		 No No No Yes
1600038 Valence Cdk Spv, L.p. C/O Valence Life Sciences Llc
590 Madison Avenue, 21St Floor
New York NY 10022		 No No No Yes
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-09-30 200 $1.67 159,986 No 4 P Direct
Common Stock Acquisiton 2015-09-30 5,000 $1.62 164,986 No 4 P Direct
Common Stock Acquisiton 2015-09-30 2,000 $1.68 166,986 No 4 P Direct
Common Stock Acquisiton 2015-09-30 3,000 $1.66 169,986 No 4 P Direct
Common Stock Acquisiton 2015-10-01 2,000 $1.64 171,986 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,123,612 Indirect See Footnote
Footnotes
  1. The reported securities are directly owned by Valence CDK SPV, L.P. ("CDK SPV"). Valence Life Sciences GP II, LLC ("GP II") is the sole general partner of CDK SPV. In his capacity as the sole manager of GP II, Eric Roberts shares voting and investment authority over the securities held by CDK SPV. GP II and Mr. Roberts may be deemed to beneficially own the securities held by CDK SPV. Mr. Roberts and GP II disclaim beneficial ownership of these securities except to the extent of their respective pecuniary interests therein.